INTECH Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $869K | Sell |
15,814
-16,318
| -51% | -$897K | 0.01% | 1277 |
|
|
2025
Q1 | $2.27M | Sell |
32,132
-129,603
| -80% | -$9.16M | 0.02% | 686 |
|
|
2024
Q4 | $10.6M | Buy |
161,735
+107,879
| +200% | +$7.09M | 0.1% | 160 |
|
|
2024
Q3 | $3.79M | Sell |
53,856
-4,167
| -7% | -$293K | 0.04% | 321 |
|
|
2024
Q2 | $4.78M | Buy |
58,023
+21,669
| +60% | +$1.78M | 0.06% | 263 |
|
|
2024
Q1 | $3.18M | Buy |
36,354
+11,186
| +44% | +$977K | 0.04% | 294 |
|
|
2023
Q4 | $2.43M | Sell |
25,168
-3,949
| -14% | -$381K | 0.04% | 313 |
|
|
2023
Q3 | $2.58M | Buy |
29,117
+1,237
| +4% | +$109K | 0.04% | 318 |
|
|
2023
Q2 | $2.42M | Buy |
27,880
+3,537
| +15% | +$307K | 0.02% | 353 |
|
|
2023
Q1 | $2.37M | Buy |
24,343
+10,539
| +76% | +$1.02M | 0.02% | 438 |
|
|
2022
Q4 | $1.43M | Buy |
13,804
+706
| +5% | +$73.1K | 0.01% | 475 |
|
|
2022
Q3 | $1.11M | Sell |
13,098
-11,131
| -46% | -$944K | 0.01% | 495 |
|
|
2022
Q2 | $2.01M | Buy |
+24,229
| New | +$2.01M | 0.01% | 451 |
|